Doctors and Healthcare Practitioners
LivStrong Plus Classic
- Clinical Trial in Taiwan conducted over 4 weeks on exclusive intake of LivStrong Plus Classic.
- The nutritional status and physiological, biochemical functions of participants were maintained in the long-term care institutions.
- There were no gastrointestinal issues observed in the duration of the trials.
- This study demonstrates that LivStrong Plus Classic is well tolerated and safe, suitable as high protein enteral feeding formula for long-term feeding.
LivStrong Diabetes Formula
- Clinical study conducted by Chung Shan University Hospital on 30 tube-feeding diabetic patients over 8 weeks
- No signs of Gastrointestinal distress or discomfort and no changes in defecation habits or frequency
- Study demonstrates that LivStrong Diabetes Formula effectively decrease concentrations of fasting blood glucose, making it a good nutrient source for diabetic patient requiring blood glucose control
- Fasting blood glucose, total cholesterol, and low density lipoprotein concentration levels decreased significantly while overall blood glucose and blood lipid index showed signs of improvement. There were no abnormalities in kidney or liver function
Nu Lopo (Chronic Kidney Disease)
- Clinical studies conducted on 109 patients with Chronic Kidney Disease (CKD) stage 3 and 4
- Our results show that caloric requirements and protein restrictions can be achieved in patients with CKD using an NPC supplement while significantly reducing proteinuria.
- Our results also indicate that the use of the Non Protein Calorie (NPC) supplement combined with nutritional counseling improves low-protein diet adherence.
PubMed Link
Nu Reno (Dialysis)
- Clinical trial on 19 Hyperlipidemic and 18 normolipidemic hemodialysis patients for 12 weeks
- Replacement of daily protein with 30g soy protein produced significant decrease in TC, LDL-C, non-HDL-C and apoB concentration and significant increases in HDL-C level in hyperlipidemic hemodialysis patients
- Soy Protein has beneficial effect on serum lipid profile: substitution has lipid-lowering effects in hyperlipidemic hemodialysis patients
PubMed Link